EGFR Mutational Analysis (Lung (8th 2018-2024))
Organization | Field Name | ID# | ID Name | Required |
---|---|---|---|---|
KCR | EGFR Mutational Analysis | 34128 | EgfrMutationalAnalysis | yes |
SEER | EGFR Mutational Analysis | egfrMutationalAnalysis | yes |
Note 1 Effective years
This SSDI is effective for diagnosis years 2021+
For cases diagnosed 2018-2020, this SSDI must be blank
Note 2 Physician Statement
Physician statement of EGFR can be used to code this data item when no other information is available.
Note 3 Applicable histologies/stages
EGFR may be recorded for all histologies and stages; however, it is primarily performed for advanced non-small cell carcinomas. If information is not available, code 9.
Note 4 Neoadjuvant Therapy
Record the assay from tumor specimens prior to neoadjuvant therapy.
If neoadjuvant therapy is given and there are no EGFR results from pre-treatment specimens, report the findings from post-treatment specimens.
Code | Description |
---|---|
0 | Normal |
1 | Abnormal (mutated)/detected in exon(s) 18, 19, 20, and/or 21 |
2 | Abnormal (mutated)/detected but not in exon(s) 18, 19, 20, and/or 21 |
4 | Abnormal (mutated)/detected, NOS, exon(s) not specified |
7 | Test ordered, results not in chart |
8 | Not applicable: Information not collected for this case |
9 | Not documented in medical record |
<BLANK> | Must be blank if diagnosis year is before 2021 |